Scott A. Waldman

powered by
COS Expertise®
Thomas Jefferson University
Thomas Jefferson University Hospital
Pharmacology and Experimental Therapeutics
Thomas Jefferson University
Jefferson Medical College
Department of Biochemistry & Molecular Pharmacology
Professor
Thomas Jefferson University
Jefferson Medical College
Department of Medicine
Division of Clinical Pharmacology
Professor

Mailing Address

Philadelphia, Pennsylvania 19107-5587
United States

Contact Information

Phone: (215) 955-6086
Fax: (215) 955-5681
Scott.Waldman@jefferson.edu

Qualifications

Ph.D..
Ph.D..

Expertise and Research Interests

Research Interests:

1. Molecular mechanisms regulating guanylyl cyclases;
2. Transcription factors mediating tissue-specific expression of proteins;
3. Molecular markers and cancer;
4. Role of cyclic GMP in regulating proliferation and differentiation;
5. Human investigation of pharmaceutical agents.

Keywords

COS Keywords:

Health and Medicine.

Additional Terms:

Fetal Disorders, Physical Disabilities, Pregnancy Complications, Prenatal Diagnosis, Reproductive Genetics.

Publications

  • Lucas KA, Pitari GM, Kazerounian S, Ruiz-Stewart I, Park J, Schulz S, Chepenik KP, Waldman SA, Guanylyl cyclases and signaling by cyclic GMP, Pharmacological Reviews, 52(3), 375-414, September 2000 Abstract
  • Park J, Schulz S, Waldman SA, Intestine-specific activity of the human guanylyl cyclase C promoter is regulated by Cdx2, Gastroenterology, 119(1), 89-96, July 2000 Abstract
  • Zannikos PN, Jensen BK, Boutouyrie BX, Tripp L, Yongyi L, McGowan T, Waldman SA, Greenberg HE, Pharmacokinetics and safety of single intravenous infusions of the adenosine agonist, AMP 579, in patients with end-stage renal insufficiency, Journal of Clinical Pharmacology, 40(7), 745-51, July 2000 Abstract
  • Weinberg DS, So C, Ruggeri B, Biswas S, Barber M, Waldman S, Human cholecystokinin-A receptor is not an oncofetal protein, Digestive Diseases and Sciences, 45(3), 538-43, March 2000 Abstract
  • Pearlman JM, Prawer SP, Barber MT, Parkinson SJ, Schulz S, Park J, Zook M, Waldman SA, A splice variant of the transcript for guanylyl cyclase C is expressed in human colon and colorectal cancer cells, Digestive Diseases and Sciences, 45(2), 298-305, February 2000 Abstract
  • Gelmann, A, Desnoyers R, Cagir B, Weinberg D, Boman B, Waldman SA, Colorectal cancer staging and adjuvant chemotherapy, Expert Opinion on Pharmacotherapy, 1, 727-755, 2000
  • Weinberg DS, Desnoyers R, Gelmann A, Boman BM, Waldman SA, Post-operative management of local colorectal cancer: Therapy and surveillance, Seminars in Gastrointestinal Disease, 11, 1-6, 2000
  • Cagir B, Gelmann A, Park J, Fava T, Tankelevitch A, Bittner EW, Weaver EJ, Palazzo JP, Weinberg D, Fry RD, Waldman SA, Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer, Annals of Internal Medicine, 131(11), 805-12, December 1999 Abstract
  • Parkinson SJ, Jovanovic A, Jovanovic S, Wagner F, Terzic A, Waldman SA, Regulation of nitric oxide-responsive recombinant soluble guanylyl cyclase by calcium, Biochemistry, 38(20), 6441-8, May 1999 Abstract
  • Zhang W, Mannan I, Schulz S, Parkinson SJ, Alekseev AE, Gomez LA, Terzic A, Waldman SA, Interruption of transmembrane signaling as a novel antisecretory strategy to treat enterotoxigenic diarrhea, Faseb Journal, 13(8), 913-22, May 1999 Abstract

Profile Details

Last Updated: 3/14/2006

COS Expertise ID #942049
Reference this profile directly: http://myprofile.cos.com/waldman11